Sort   by:  
 Page size 
GenomicsModeling ischemic cholangiopathy in human cholangiocyte organoid for screening of novel cholangio-protective agents
Modeling ischemic cholangiopathy in human cholangiocyte organoid for screening of novel cholangio-protective agents
PRJNA817199 | ENA
TranscriptomicsModeling ischemic cholangiopathy in human cholangiocyte organoid for screening of novel cholangio-protective agents
Ischemic cholangiopathy refers to biliary damage caused by disruption of blood supply in the peribiliary plexus. Detailed knowledge of ischemic cholangiopathy pathogenesis remains scarce due to the lack of appropriate in vitro models. We aimed to recapitulate ischemia-evoked biliary damage using hum...
ORGANISM(S): Homo sapiens 
2022-11-01 | GSE198860 | GEO
UnknownPost-COVID-19 Cholangiopathy: A Systematic Review.
Not available
S-EPMC9618303 | biostudies-literature
UnknownCOVID-19 Induced Cholangiopathy: A Case Report.
Not available
S-EPMC12266703 | biostudies-literature
UnknownPivotal roles of Kupffer cells in the progression and regression of DDC-induced chronic cholangiopathy.
Not available
S-EPMC5913224 | biostudies-literature
UnknownDiet-Induced Dysbiosis and Genetic Background Synergize With Cystic Fibrosis Transmembrane Conductance Regulator Deficiency to Promote Cholangiopathy in Mice.
Not available
S-EPMC6287479 | biostudies-literature
UnknownCOVID-19-Related Cholangiopathy: Histological Findings.
Not available
S-EPMC11354040 | biostudies-literature
UnknownPost-COVID-19 cholangiopathy: Current understanding and management options.
Not available
S-EPMC10277943 | biostudies-literature
UnknownCombining ASBT inhibitor and FGF15 treatments enhances therapeutic efficacy against cholangiopathy in female but not male Cyp2c70 KO mice.
Not available
S-EPMC9986646 | biostudies-literature
UnknownPortal cavernoma cholangiopathy: an endoscopic ultrasound based imaging approach.
Not available
S-EPMC4244829 | biostudies-literature
Sort   by:  
 Page size